Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells

Area of Science:

• Molecular Biology
• Cell Signaling
• Oncology

Background:

• Elevated Src tyrosine protein kinase activity is common in human cancers, making it a potential therapeutic target.
• The mTOR signaling pathway plays a critical role in cell growth and proliferation, and its deregulation is implicated in various malignancies.

Purpose of the Study:

• To investigate the role of Src activity in regulating the mTOR signaling pathway in Rous sarcoma virus (RSV)-transformed hamster fibroblasts (H19 cells).
• To determine if Src kinase activity is essential for the activation of mTOR-dependent signaling components.

Main Methods:

• Treatment of H19 cells with a Src-specific inhibitor (SU6656).
• Utilized fibroblast clones expressing either active Src or a dominant-negative Src kinase-dead mutant.
• Assessed the phosphorylation and activity of key signaling proteins including Akt/protein kinase B (PKB), tuberin (TSC2), mTOR, S6K1, ribosomal protein S6, and eukaryotic initiation factor 4E-binding protein 4E-BP1.

Main Results:

• Disruption of Src kinase activity led to a significant reduction in the phosphorylation and activity of Akt/PKB, TSC2, mTOR, S6K1, S6, and 4E-BP1.
• Ectopic expression of active Akt1 in Src-deficient cells increased TSC2 phosphorylation but did not restore the activity of downstream mTOR pathway components.
• Src kinase activity is essential for mTOR-dependent signaling, and Src may control mTOR targets independently of the Akt1/TSC2 cascade.

Conclusions:

• Src kinase activity is indispensable for the functional integrity of the mTOR signaling pathway.
• Src influences mTOR signaling independently of the Akt1/TSC2 pathway in cells with hyperactive Src.
• These findings suggest potential implications for drug resistance in mTOR inhibitor-based cancer therapy.